Given that predictive markers for other epithelial cancers such as mutations in KRAS, EGFR or BRAF are rarely detected in esophageal cancers, EGFR expression has been predominantly investigated for its potentiality of predicting treatment outcome for esophageal cancers [18-21]. This evidence concerns the gene BRAF and esophageal cancer.